LLY
- Eli Lilly and Company
()
Overview
Company Summary
Eli Lilly and Company (LLY) is a major pharmaceutical company that operates globally. The company focuses on developing and manufacturing innovative medicines and treatments for various medical conditions, primarily in the areas of neuroscience, diabetes, immunology, oncology, and cardiovascular health.
LLY conducts extensive research and development to discover new drugs and therapies that can address unmet medical needs. Their portfolio includes a wide range of prescription medications, including both small molecule drugs and biologics (medicines made from living organisms).
Some notable products developed by Eli Lilly include Humalog and Humulin insulin formulations for diabetes management, Prozac for psychiatric disorders, Taltz for autoimmune diseases such as psoriasis and arthritis, and Alimta for certain types of cancer treatment.
In addition to prescription drugs, Eli Lilly also invests in animal health products through its subsidiary, Elanco Animal Health. Elanco focuses on developing treatments and vaccines for pets, livestock, and poultry, contributing to the well-being of animals worldwide.
Overall, Eli Lilly and Company is dedicated to improving patient outcomes and enhancing the quality of life through the discovery, development, and commercialization of innovative pharmaceutical products. The company's mission is to make life better for individuals globally by advancing accessible and effective treatments across a wide range of therapeutic areas.